Eruptive basal cell carcinoma and lenalidomide: rising awareness among dermatologists. Dermatology Reports, [S. l.], v. 15, n. 1, 2022. DOI: 10.4081/dr.2022.9534. Disponível em: https://journals.pagepress.org/dr/article/view/9534. Acesso em: 19 jun. 2025.